Zynex to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
11/24/2021 - 04:05 PM
ENGLEWOOD, Colo., Nov. 24, 2021 /PRNewswire/ -- Zynex, Inc rd Annual Virtual Healthcare Conference. Presentations will be available for registered attendees via the Piper Sandler conference site from November 22 nd to December 2 nd . The company will be participating in 1X1 meetings from November 29 th - December 2 nd , meetings may be requested exclusively via Piper Sandler.
Corporate Presentation with Zynex CFO, Dan Moorhead : https://pipersandler.zoom.us/rec/play/cNlPGbiBfNUQ0sl52uOdOqwVS3H-MEiYAz5nQRk_GSWXY91ZQ-17t1LqUXfR9oUGYKuuzf443CXh8y1l.4G8KXbfclNtGlXgw
About Zynex, Inc. Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex also has a fluid monitoring system for use in hospitals and surgery centers. For additional information, please visit: www.zynex.com
Contact: Zynex, Inc.
Investor Relations Contact: admin@amatoandpartners.com
https://www.prnewswire.com/news-releases/zynex-to-present-at-the-piper-sandler-33rd-annual-virtual-healthcare-conference-301431772.html
SOURCE Zynex
ZYXI Rankings
#3699 Ranked by Stock Gains
ZYXI Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Medical Specialties, Health Technology, Manufacturing, Surgical and Medical Instrument Manufacturing
About ZYXI
zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.
